c.castellanos
TL2 · Mysuru
Contributes reviews on supplier material. Based in Mysuru.
Joined 24 May 2025 · last posted 3d
108Posts here
4Topics
0Solutions
134Likes received
163Likes given
19Badges
99Days visited
984Posts read
Recent activity
Full stream-
What a reversed-phase purity number actually is Replied, post #90 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 28 likes Agreed on reversed-phase purity number, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and…
-
A critique that turned out to be unfair, retracted by its author Replied, post #37 · Evidence › Study critique · 24 Jul 2026 · 0 likes I read post #35 twice before replying, because I had assumed the opposite. The version of critique that circulates here is a simplification of a simplification. It is…
-
Prescription portability between countries Replied, post #109 · Access › International · 23 Jul 2026 · 1 like Prescription portability between countries looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not…
-
Why the cheapest option is often not the cheapest Replied, post #22 · Access › Pricing · 22 Jul 2026 · 2 likes Seconded. It reads as careful rather than confident, which is the right register.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #89 · Access › International · 18 Jul 2026 · 0 likes I read post #87 twice before replying, because I had assumed the opposite. Country-by-country legality: compound approval and legal status differ substantially by…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #6 · Compounds › Tirzepatide · 15 Jul 2026 · 7 likes Sensible. I would want the same detail before I acted on it either.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #88 · Start Here › Welcome · 6 Jul 2026 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Forced degradation studies: designing one that is informative Replied, post #87 · Analytics › Method validation · 29 Jun 2026 · 32 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
-
Retatrutide mass and identity: what a report should show Replied, post #4 · Compounds › Retatrutide · 25 Jun 2026 · 3 likes I would be cautious about generalising from the retatrutide mass and identity example above. It is a good example. It is one example.
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #13 · Lounge › Off topic · 25 Jun 2026 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
-
Fasting versus non-fasting and which tests care Replied, post #54 · Clinical › Bloodwork · 23 Jun 2026 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #70 · Safety › Contraindications · 12 Jun 2026 · 11 likes Coming back to post #68, because the follow-up matters more than the original answer. Allergy to the specific compound: true allergy is rare but possible. Any prior…